HPV Vaccine Reminders - SEARCH II Study

Description

This RCT will take place at health centres and their affiliated schools and community immunization centers overseen by the Kampala Capital City Authority (KCCA) as well as at the Makerere/Mulago/Columbia Adolescent Health Clinic in Kampala. The investigators will assess the impact of vaccine text message and automated phone reminders on human papillomavirus (HPV) vaccination initiation and completion.

Conditions

Human Papillomavirus Vaccination

Study Overview

Study Details

Study overview

This RCT will take place at health centres and their affiliated schools and community immunization centers overseen by the Kampala Capital City Authority (KCCA) as well as at the Makerere/Mulago/Columbia Adolescent Health Clinic in Kampala. The investigators will assess the impact of vaccine text message and automated phone reminders on human papillomavirus (HPV) vaccination initiation and completion.

SEARCH II: Short Message Service (SMS) Electronic Adolescent Reminders for Completion of HPV Vaccination - Uganda: Randomized Controlled Trial

HPV Vaccine Reminders - SEARCH II Study

Condition
Human Papillomavirus Vaccination
Intervention / Treatment

-

Contacts and Locations

New York

Columbia University Irving Medical Center, New York, New York, United States, 10032

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Be a parenting adult of an adolescent girl aged 10-14 years
  • * Reside in Kampala and/or the surrounding districts
  • * Speak English or Luganda
  • * Have a cell phone with text messaging capability
  • * Must have ability to consent
  • * Parenting adult speaks other language than English or Luganda only
  • * Parenting adult already enrolled in the study for another child
  • * Participation in previous HPV vaccine reminder study

Ages Eligible for Study

10 Years to 14 Years

Sexes Eligible for Study

FEMALE

Accepts Healthy Volunteers

No

Collaborators and Investigators

Columbia University,

Melissa S Stockwell, MD MPH, PRINCIPAL_INVESTIGATOR, Columbia University

Study Record Dates

2026-07-31